By API User
Key Highlights • Record quarterly dose sales reported in the March 2025 quarter, on the back of continued growth in clinical adoption of the OncoSil™ device • Advisory Board Meetings in UK and Germany define strategic pathways for OncoSil™ device • OncoSil Medical receives $1.05m R&D tax incentive • Ms Lel Smits appointed to OncoSil Medical Board of … Continued
By API User
Magellan Stem Cell researchers have been honoured with a Research Publication of the Year Award by a prestigious international medical journal. The Melbourne-based researchers won the Osteoarthritis and Cartilage Open Clinical Research Publication of the Year Award for the excellence of their original research. The results of Magellan’s Phase I/IIa trials of Magellan’s off-the-shelf … Continued
By API User
Highlights CLEO signs Collaboration Agreement with University College London (UCL) to accelerate test development, securing access to ~2,000 high-quality blood samples Samples sourced from UKCTOCS, the world’s largest Ovarian Cancer screening trial, to strengthen CLEO’s clinical validation program Collaboration with UCL and renowned Ovarian Cancer expert, Professor Usha Menon, will evaluate CLEO’s technology in two clinical studies focussed on … Continued
By API User
LUXEMBOURG, LU / ACCESS Newswire / April 21, 2025 / Moolec Science SA (NASDAQ:MLEC) ("The Company" or "Moolec"), a science-based food ingredient company focused on producing animal proteins and nutritional oils in plants, today announced that it has entered into a Business Combination Agreement (the "BCA") with Bioceres Group Limited ("Bioceres Group") and other related … Continued
By API User
Melbourne, Australia – 10 April 2025 | ReNerve Limited (ASX: RNV) (“ReNerve” or the “Company”), an Australian medical device company specialising in peripheral nerve repair technologies, is pleased to announce it has entered into a strategic partnership with NetCentrix Ventures to establish and expand its operations in the Indian healthcare market. This agreement marks a … Continued
By API User
During the visit, attendees will receive a detailed overview of Optiscan’s strategic direction, commercialisation progress, and key milestones across its three core markets: • Medical – advancing real-time digital pathology and precision surgery• Veterinary – expanding imaging capabilities into animal healthcare • Life Sciences – enabling high-resolution live-cell imaging in preclinical research The visit will include live … Continued
By API User
These senior executive team changes mean Optiscan is now better resourced to implement its transformation plan and future-focussed priorities. Highlights • Optiscan’s current Finance Manager, Mr Darius Ooi, has been promoted to the Chief Financial Officer role, and will now lead the Corporate team. • Ms Belinda Williamson has been appointed as Chief Commercial Officer, and … Continued
By API User
Perth, Australia – 1 April 2025 | BlinkLab Limited (ASX: BB1) (“BlinkLab” or the “Company”) is pleased to announce it has successfully recruited 54 children as participants, surpassing the halfway point of the initial 100-patient phase of its pivotal U.S. clinical trial to validate the Company’s AI-powered smartphone-based autism diagnostic tool. The trial is part … Continued
By API User
28 March 2025 | ReNerve Limited (ASX: RNV) (“ReNerve” or “the Company”), a medical device company focused on innovative products aimed at nerve repair and regeneration, is pleased to announce positive clinical data demonstrating the significant benefits of using the Company’s NervAlign® Nerve Cuff in peripheral nerve repair surgery. The study results, presented this week … Continued
By API User
26 March 2025 – LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to provide an update to the Company’s commercial and regulatory processes, highlighting the strong progress that has been made toward the global commercialisation and approvals for its innovative intranasal erectile dysfunction (ED) treatment, SPONTAN®. Highlights Successful FDA pre-IND meeting has … Continued
